Bubalus bubalis isolate 160015118507 breed Murrah chromosome 19, NDDB_SH_1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; Bovinae; Bubalus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM034289.1.\nAssembly name: NDDB_SH_1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the National Dairy Development\nBoard, India on 2021/09/10. The original whole-genome shotgun\nproject has the accession VDCB00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: National Dairy Development Board, India\nAssembly Date :: 25-FEB-2019\nAssembly Method :: Falcon+Scaff10X+BioNano v. 2019-02-25\nAssembly Name :: NDDB_SH_1\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 572.0x\nSequencing Technology :: PacBio Sequel; 10X and BioNano Optical\n Map\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Bubalus bubalis Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
S-antigen protein, transcript variant X5
COORDINATES: polyA evidence [ECO:0006239]
S-antigen protein, transcript variant X8
S-antigen protein, transcript variant X4
S-antigen protein, transcript variant X3
S-antigen protein, transcript variant X7
S-antigen protein, transcript variant X2
S-antigen protein, transcript variant X1
S-antigen protein, transcript variant X6
uncharacterized protein LOC123330535 isoform X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 37% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
pantothenate kinase 3, transcript variant X1
pantothenate kinase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 75 samples with support for all annotated introns
slit guidance ligand 3, transcript variant X1
slit guidance ligand 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123465172, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123465172, transcript variant X1
spindle apparatus coiled-coil protein 1, transcript variant X5
spindle apparatus coiled-coil protein 1, transcript variant X6
spindle apparatus coiled-coil protein 1, transcript variant X2
spindle apparatus coiled-coil protein 1, transcript variant X7
spindle apparatus coiled-coil protein 1, transcript variant X1
spindle apparatus coiled-coil protein 1, transcript variant X3
spindle apparatus coiled-coil protein 1, transcript variant X4
dedicator of cytokinesis 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dedicator of cytokinesis 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
dedicator of cytokinesis 2, transcript variant X1
dedicator of cytokinesis protein 2 isoform X1
dedicator of cytokinesis protein 2 isoform X3
dedicator of cytokinesis protein 2 isoform X2
inhibitory synaptic factor family member 2B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
chromosome 19 C5orf58 homolog, transcript variant X1
chromosome 19 C5orf58 homolog, transcript variant X4
chromosome 19 C5orf58 homolog, transcript variant X3
chromosome 19 C5orf58 homolog, transcript variant X2
putative uncharacterized protein C5orf58 homolog
lymphocyte cytosolic protein 2, transcript variant X5
lymphocyte cytosolic protein 2, transcript variant X4
lymphocyte cytosolic protein 2 isoform X5
lymphocyte cytosolic protein 2 isoform X4
lymphocyte cytosolic protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
lymphocyte cytosolic protein 2, transcript variant X6
lymphocyte cytosolic protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
lymphocyte cytosolic protein 2, transcript variant X2
lymphocyte cytosolic protein 2, transcript variant X1
lymphocyte cytosolic protein 2 isoform X2
lymphocyte cytosolic protein 2 isoform X1
lymphocyte cytosolic protein 2 isoform X6
lymphocyte cytosolic protein 2 isoform X7
lymphocyte cytosolic protein 2 isoform X3
lymphocyte cytosolic protein 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
lymphocyte cytosolic protein 2 isoform X8
potassium voltage-gated channel interacting protein 1, transcript variant X4
potassium voltage-gated channel interacting protein 1, transcript variant X1
potassium voltage-gated channel interacting protein 1, transcript variant X2
Kv channel-interacting protein 1 isoform X1
Kv channel-interacting protein 1 isoform X2
potassium calcium-activated channel subfamily M regulatory beta subunit 1
calcium-activated potassium channel subunit beta-1
potassium voltage-gated channel interacting protein 1, transcript variant X3
Kv channel-interacting protein 1 isoform X3
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Kv channel-interacting protein 1 isoform X4
gamma-aminobutyric acid type A receptor subunit pi, transcript variant X1
gamma-aminobutyric acid type A receptor subunit pi, transcript variant X2
gamma-aminobutyric acid receptor subunit pi isoform X1
gamma-aminobutyric acid receptor subunit pi isoform X2
RAN binding protein 17, transcript variant X1
RAN binding protein 17, transcript variant X4
RAN binding protein 17, transcript variant X2
RAN binding protein 17, transcript variant X3
RAN binding protein 17, transcript variant X6
RAN binding protein 17, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123330573, transcript variant X1
uncharacterized LOC123330573, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
F-box and WD repeat domain containing 11, transcript variant X1
F-box and WD repeat domain containing 11, transcript variant X2
F-box and WD repeat domain containing 11, transcript variant X4
F-box and WD repeat domain containing 11, transcript variant X5
F-box and WD repeat domain containing 11, transcript variant X3
F-box/WD repeat-containing protein 11 isoform X5
F-box/WD repeat-containing protein 11 isoform X3
F-box/WD repeat-containing protein 11 isoform X2
F-box/WD repeat-containing protein 11 isoform X1
F-box/WD repeat-containing protein 11 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 20% coverage of the annotated genomic feature by RNAseq alignments
EF-hand calcium-binding domain-containing protein 9
ubiquitin domain containing 2, transcript variant X1
ubiquitin domain containing 2, transcript variant X2
ubiquitin domain-containing protein 2 isoform X1
ubiquitin domain-containing protein 2 isoform X2
neuralized E3 ubiquitin protein ligase 1B, transcript variant X1
neuralized E3 ubiquitin protein ligase 1B, transcript variant X2
E3 ubiquitin-protein ligase NEURL1B isoform X1
E3 ubiquitin-protein ligase NEURL1B isoform X2
endoplasmic reticulum-golgi intermediate compartment 1
endoplasmic reticulum-Golgi intermediate compartment protein 1
uncharacterized LOC123330547, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC123330547, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
CREB3 regulatory factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
CREB3 regulatory factor, transcript variant X1
CREB3 regulatory factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123330651, transcript variant X2
uncharacterized LOC123330651, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
biorientation of chromosomes in cell division 1
biorientation of chromosomes in cell division protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
cytoplasmic polyadenylation element binding protein 4, transcript variant X1
cytoplasmic polyadenylation element binding protein 4, transcript variant X3
cytoplasmic polyadenylation element binding protein 4, transcript variant X2
cytoplasmic polyadenylation element-binding protein 4 isoform X1
cytoplasmic polyadenylation element-binding protein 4 isoform X2
cytoplasmic polyadenylation element-binding protein 4 isoform X3
chromosome 19 C5orf47 homolog, transcript variant X5
chromosome 19 C5orf47 homolog, transcript variant X6
chromosome 19 C5orf47 homolog, transcript variant X1
chromosome 19 C5orf47 homolog, transcript variant X3
chromosome 19 C5orf47 homolog, transcript variant X2
uncharacterized protein C5orf47 homolog isoform X1
uncharacterized protein C5orf47 homolog isoform X5
uncharacterized protein C5orf47 homolog isoform X4
uncharacterized protein C5orf47 homolog isoform X2
chromosome 19 C5orf47 homolog, transcript variant X4
chromosome 19 C5orf47 homolog, transcript variant X7
uncharacterized protein C5orf47 homolog isoform X3
uncharacterized protein C5orf47 homolog isoform X6
neuronal vesicle trafficking associated 2
neuronal vesicle trafficking-associated protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 169 member A, transcript variant X4
family with sequence similarity 169 member A, transcript variant X2
family with sequence similarity 169 member A, transcript variant X1
family with sequence similarity 169 member A, transcript variant X5
family with sequence similarity 169 member A, transcript variant X3
soluble lamin-associated protein of 75 kDa isoform X1
soluble lamin-associated protein of 75 kDa isoform X2
family with sequence similarity 169 member A, transcript variant X6
soluble lamin-associated protein of 75 kDa isoform X3
ribosome biogenesis protein NSA2 homolog
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X5
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X6
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X7
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X8
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X9
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X4
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X1
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X3
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X2
ribosome-releasing factor 2, mitochondrial isoform X1
ribosome-releasing factor 2, mitochondrial isoform X2
ribosome-releasing factor 2, mitochondrial isoform X3
ribosome-releasing factor 2, mitochondrial, transcript variant X10
ribosome-releasing factor 2, mitochondrial, transcript variant X6
ribosome-releasing factor 2, mitochondrial, transcript variant X4
ribosome-releasing factor 2, mitochondrial, transcript variant X21
ribosome-releasing factor 2, mitochondrial, transcript variant X17
ribosome-releasing factor 2, mitochondrial, transcript variant X27
ribosome-releasing factor 2, mitochondrial, transcript variant X24
ribosome-releasing factor 2, mitochondrial, transcript variant X23
ribosome-releasing factor 2, mitochondrial, transcript variant X11
ribosome-releasing factor 2, mitochondrial, transcript variant X12
ribosome-releasing factor 2, mitochondrial, transcript variant X20
ribosome-releasing factor 2, mitochondrial, transcript variant X15
ribosome-releasing factor 2, mitochondrial, transcript variant X26
ribosome-releasing factor 2, mitochondrial, transcript variant X8
ribosome-releasing factor 2, mitochondrial, transcript variant X25
ribosome-releasing factor 2, mitochondrial, transcript variant X22
ribosome-releasing factor 2, mitochondrial, transcript variant X16
ribosome-releasing factor 2, mitochondrial, transcript variant X9
ribosome-releasing factor 2, mitochondrial, transcript variant X7
ribosome-releasing factor 2, mitochondrial, transcript variant X5
ribosome-releasing factor 2, mitochondrial, transcript variant X19
ribosome-releasing factor 2, mitochondrial, transcript variant X14
ribosome-releasing factor 2, mitochondrial, transcript variant X18
ribosome-releasing factor 2, mitochondrial, transcript variant X13
ribosome-releasing factor 2, mitochondrial, transcript variant X3
ribosome-releasing factor 2, mitochondrial, transcript variant X2
ribosome-releasing factor 2, mitochondrial, transcript variant X1
uncharacterized LOC123330581, transcript variant X2
uncharacterized LOC123330581, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123330604, transcript variant X2
uncharacterized LOC123330604, transcript variant X1
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Rho guanine nucleotide exchange factor 28, transcript variant X6
Rho guanine nucleotide exchange factor 28, transcript variant X9
Rho guanine nucleotide exchange factor 28, transcript variant X5
Rho guanine nucleotide exchange factor 28, transcript variant X3
Rho guanine nucleotide exchange factor 28, transcript variant X1
Rho guanine nucleotide exchange factor 28, transcript variant X8
Rho guanine nucleotide exchange factor 28, transcript variant X4
Rho guanine nucleotide exchange factor 28, transcript variant X7
Rho guanine nucleotide exchange factor 28, transcript variant X11
rho guanine nucleotide exchange factor 28 isoform X8
rho guanine nucleotide exchange factor 28 isoform X3
rho guanine nucleotide exchange factor 28 isoform X1
rho guanine nucleotide exchange factor 28 isoform X7
rho guanine nucleotide exchange factor 28 isoform X4
rho guanine nucleotide exchange factor 28 isoform X5
rho guanine nucleotide exchange factor 28 isoform X6
rho guanine nucleotide exchange factor 28 isoform X10
Rho guanine nucleotide exchange factor 28, transcript variant X2
rho guanine nucleotide exchange factor 28 isoform X2
Rho guanine nucleotide exchange factor 28, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
rho guanine nucleotide exchange factor 28 isoform X9
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
UTP15 small subunit processome component, transcript variant X3
UTP15 small subunit processome component, transcript variant X1
UTP15 small subunit processome component, transcript variant X4
UTP15 small subunit processome component, transcript variant X2
U3 small nucleolar RNA-associated protein 15 homolog isoform X2
U3 small nucleolar RNA-associated protein 15 homolog isoform X1
ankyrin repeat family A member 2, transcript variant X1
ankyrin repeat family A member 2, transcript variant X2
ankyrin repeat family A protein 2 isoform X1
ankyrin repeat family A protein 2 isoform X2
ankyrin repeat family A member 2, transcript variant X3
ankyrin repeat family A protein 2 isoform X3
basic transcription factor 3, transcript variant X2
basic transcription factor 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 171, transcript variant X4
transmembrane protein 171, transcript variant X3
transmembrane protein 171, transcript variant X1
transmembrane protein 171, transcript variant X2
FCH and mu domain containing endocytic adaptor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 366, transcript variant X1
zinc finger protein 366, transcript variant X2
pentatricopeptide repeat domain 2, transcript variant X2
pentatricopeptide repeat domain 2, transcript variant X1
pentatricopeptide repeat domain 2, transcript variant X4
pentatricopeptide repeat domain 2, transcript variant X3
pentatricopeptide repeat-containing protein 2, mitochondrial isoform X2
pentatricopeptide repeat-containing protein 2, mitochondrial isoform X1
pentatricopeptide repeat-containing protein 2, mitochondrial isoform X3
pentatricopeptide repeat-containing protein 2, mitochondrial isoform X4
mitochondrial ribosomal protein S27, transcript variant X4
mitochondrial ribosomal protein S27, transcript variant X3
mitochondrial ribosomal protein S27, transcript variant X1
mitochondrial ribosomal protein S27, transcript variant X2
28S ribosomal protein S27, mitochondrial isoform X3
28S ribosomal protein S27, mitochondrial isoform X1
28S ribosomal protein S27, mitochondrial isoform X2
28S ribosomal protein S27, mitochondrial isoform X4
microtubule associated protein 1B, transcript variant X1
microtubule associated protein 1B, transcript variant X2
microtubule-associated protein 1B isoform X1
microtubule-associated protein 1B isoform X2
cocaine- and amphetamine-regulated transcript protein
methylcrotonyl-CoA carboxylase subunit 2
methylcrotonoyl-CoA carboxylase beta chain, mitochondrial
peptidyl-prolyl cis-trans isomerase FKBP2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB
transcription factor TFIIIB component B'' homolog
survival motor neuron protein, transcript variant X2
survival motor neuron protein, transcript variant X1
survival motor neuron protein, transcript variant X4
survival motor neuron protein, transcript variant X3
survival motor neuron protein isoform X1
survival motor neuron protein isoform X2
general transcription factor IIH subunit 2, transcript variant X2
general transcription factor IIH subunit 2, transcript variant X6
general transcription factor IIH subunit 2, transcript variant X3
general transcription factor IIH subunit 2, transcript variant X8
general transcription factor IIH subunit 2, transcript variant X7
general transcription factor IIH subunit 2, transcript variant X4
general transcription factor IIH subunit 2, transcript variant X5
general transcription factor IIH subunit 2, transcript variant X1
baculoviral IAP repeat-containing protein 1 isoform X2
baculoviral IAP repeat-containing protein 1 isoform X6
baculoviral IAP repeat-containing protein 1 isoform X3
baculoviral IAP repeat-containing protein 1 isoform X8
baculoviral IAP repeat-containing protein 1 isoform X7
baculoviral IAP repeat-containing protein 1 isoform X4
baculoviral IAP repeat-containing protein 1 isoform X5
baculoviral IAP repeat-containing protein 1 isoform X1
general transcription factor IIH subunit 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
baculoviral IAP repeat-containing protein 1 isoform X9
general transcription factor IIH subunit 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
general transcription factor IIH subunit 2, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
general transcription factor IIH subunit 2 isoform X12
general transcription factor IIH subunit 2 isoform X13
general transcription factor IIH subunit 2, transcript variant X10
general transcription factor IIH subunit 2 isoform X10
general transcription factor IIH subunit 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
general transcription factor IIH subunit 2 isoform X11
general transcription factor IIH subunit 2, transcript variant X14
general transcription factor IIH subunit 2 isoform X14
general transcription factor IIH subunit 2, transcript variant X15
general transcription factor IIH subunit 2 isoform X15
MARVEL domain containing 2, transcript variant X1
MARVEL domain containing 2, transcript variant X2
RAD17 checkpoint clamp loader component, transcript variant X1
RAD17 checkpoint clamp loader component, transcript variant X2
cell cycle checkpoint protein RAD17 isoform X1
cell cycle checkpoint protein RAD17 isoform X2
RAD17 checkpoint clamp loader component, transcript variant X3
cell cycle checkpoint protein RAD17 isoform X3
TATA-box binding protein associated factor 9
transcription initiation factor TFIID subunit 9
coiled-coil domain containing 125, transcript variant X4
coiled-coil domain containing 125, transcript variant X3
coiled-coil domain containing 125, transcript variant X5
coiled-coil domain containing 125, transcript variant X1
coiled-coil domain containing 125, transcript variant X2
coiled-coil domain-containing protein 125 isoform X1
coiled-coil domain-containing protein 125 isoform X2
cyclin dependent kinase 7, transcript variant X3
cyclin dependent kinase 7, transcript variant X2
cyclin dependent kinase 7, transcript variant X4
cyclin dependent kinase 7, transcript variant X1
cyclin dependent kinase 7, transcript variant X6
cyclin dependent kinase 7, transcript variant X5
mitochondrial ribosomal protein S36, transcript variant X2
mitochondrial ribosomal protein S36, transcript variant X1
28S ribosomal protein S36, mitochondrial isoform X2
28S ribosomal protein S36, mitochondrial isoform X1
phosphoinositide-3-kinase regulatory subunit 1, transcript variant X2
phosphoinositide-3-kinase regulatory subunit 1, transcript variant X1
phosphoinositide-3-kinase regulatory subunit 1, transcript variant X3
phosphoinositide-3-kinase regulatory subunit 1, transcript variant X5
phosphoinositide-3-kinase regulatory subunit 1, transcript variant X4
phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1
phosphatidylinositol 3-kinase regulatory subunit alpha isoform X3
phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2
cytochrome c oxidase subunit 7B, mitochondrial-like
microtubule associated serine/threonine kinase family member 4, transcript variant X8
microtubule associated serine/threonine kinase family member 4, transcript variant X14
microtubule associated serine/threonine kinase family member 4, transcript variant X5
microtubule associated serine/threonine kinase family member 4, transcript variant X3
microtubule associated serine/threonine kinase family member 4, transcript variant X2
microtubule associated serine/threonine kinase family member 4, transcript variant X1
microtubule associated serine/threonine kinase family member 4, transcript variant X4
microtubule associated serine/threonine kinase family member 4, transcript variant X6
microtubule associated serine/threonine kinase family member 4, transcript variant X12
microtubule associated serine/threonine kinase family member 4, transcript variant X7
microtubule associated serine/threonine kinase family member 4, transcript variant X11
microtubule associated serine/threonine kinase family member 4, transcript variant X9
microtubule associated serine/threonine kinase family member 4, transcript variant X10
microtubule associated serine/threonine kinase family member 4, transcript variant X15
microtubule associated serine/threonine kinase family member 4, transcript variant X16
microtubule associated serine/threonine kinase family member 4, transcript variant X13
microtubule associated serine/threonine kinase family member 4, transcript variant X18
microtubule associated serine/threonine kinase family member 4, transcript variant X21
microtubule associated serine/threonine kinase family member 4, transcript variant X17
microtubule associated serine/threonine kinase family member 4, transcript variant X20
microtubule associated serine/threonine kinase family member 4, transcript variant X19
microtubule associated serine/threonine kinase family member 4, transcript variant X23
microtubule associated serine/threonine kinase family member 4, transcript variant X22
microtubule-associated serine/threonine-protein kinase 4 isoform X8
microtubule-associated serine/threonine-protein kinase 4 isoform X11
microtubule-associated serine/threonine-protein kinase 4 isoform X7
microtubule-associated serine/threonine-protein kinase 4 isoform X4
microtubule-associated serine/threonine-protein kinase 4 isoform X5
microtubule-associated serine/threonine-protein kinase 4 isoform X3
microtubule-associated serine/threonine-protein kinase 4 isoform X2
microtubule-associated serine/threonine-protein kinase 4 isoform X6
microtubule-associated serine/threonine-protein kinase 4 isoform X13
microtubule-associated serine/threonine-protein kinase 4 isoform X1
microtubule-associated serine/threonine-protein kinase 4 isoform X9
microtubule-associated serine/threonine-protein kinase 4 isoform X10
microtubule-associated serine/threonine-protein kinase 4 isoform X12
microtubule-associated serine/threonine-protein kinase 4 isoform X14
microtubule-associated serine/threonine-protein kinase 4 isoform X18
microtubule-associated serine/threonine-protein kinase 4 isoform X16
microtubule-associated serine/threonine-protein kinase 4 isoform X15
microtubule-associated serine/threonine-protein kinase 4 isoform X20
microtubule-associated serine/threonine-protein kinase 4 isoform X17
microtubule-associated serine/threonine-protein kinase 4 isoform X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X2
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X1
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X5
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X4
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X3
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X6
splicing regulatory glutamine/lysine-rich protein 1 isoform X2
splicing regulatory glutamine/lysine-rich protein 1 isoform X1
splicing regulatory glutamine/lysine-rich protein 1 isoform X3
splicing regulatory glutamine/lysine-rich protein 1 isoform X4
erbb2 interacting protein, transcript variant X6
erbb2 interacting protein, transcript variant X2
erbb2 interacting protein, transcript variant X3
erbb2 interacting protein, transcript variant X1
erbb2 interacting protein, transcript variant X10
erbb2 interacting protein, transcript variant X7
erbb2 interacting protein, transcript variant X4
erbb2 interacting protein, transcript variant X8
erbb2 interacting protein, transcript variant X12
erbb2 interacting protein, transcript variant X11
erbb2 interacting protein, transcript variant X9
erbb2 interacting protein, transcript variant X5
erbb2 interacting protein, transcript variant X13
erbb2 interacting protein, transcript variant X14
small glutamine rich tetratricopeptide repeat co-chaperone beta, transcript variant X2
small glutamine rich tetratricopeptide repeat co-chaperone beta, transcript variant X1
small glutamine rich tetratricopeptide repeat co-chaperone beta, transcript variant X3
small glutamine-rich tetratricopeptide repeat-containing protein beta isoform X1
small glutamine-rich tetratricopeptide repeat-containing protein beta isoform X2
small glutamine-rich tetratricopeptide repeat-containing protein beta isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
trafficking protein particle complex subunit 13, transcript variant X4
trafficking protein particle complex subunit 13, transcript variant X3
trafficking protein particle complex subunit 13, transcript variant X2
trafficking protein particle complex subunit 13, transcript variant X1
trafficking protein particle complex subunit 13 isoform X4
trafficking protein particle complex subunit 13 isoform X3
trafficking protein particle complex subunit 13 isoform X2
trafficking protein particle complex subunit 13 isoform X1
tripartite motif containing 23, transcript variant X1
E3 ubiquitin-protein ligase TRIM23 isoform X1
tripartite motif containing 23, transcript variant X2
tripartite motif containing 23, transcript variant X3
E3 ubiquitin-protein ligase TRIM23 isoform X2
peptidylprolyl isomerase domain and WD repeat containing 1, transcript variant X1
peptidylprolyl isomerase domain and WD repeat containing 1, transcript variant X2
peptidylprolyl isomerase domain and WD repeat-containing protein 1 isoform X1
peptidylprolyl isomerase domain and WD repeat-containing protein 1 isoform X2
centromere protein K, transcript variant X3
centromere protein K, transcript variant X1
centromere protein K, transcript variant X2
ADAM metallopeptidase with thrombospondin type 1 motif 6
A disintegrin and metalloproteinase with thrombospondin motifs 6
uncharacterized LOC112580606, transcript variant X3
uncharacterized LOC112580606, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC112580606, transcript variant X6
uncharacterized LOC112580606, transcript variant X7
uncharacterized LOC112580606, transcript variant X4
uncharacterized LOC112580606, transcript variant X2
uncharacterized LOC112580606, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
CWC27 spliceosome associated cyclophilin, transcript variant X2
CWC27 spliceosome associated cyclophilin, transcript variant X1
spliceosome-associated protein CWC27 homolog isoform X1
CWC27 spliceosome associated cyclophilin, transcript variant X3
spliceosome-associated protein CWC27 homolog isoform X2
CWC27 spliceosome associated cyclophilin, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
spliceosome-associated protein CWC27 homolog isoform X3
CWC27 spliceosome associated cyclophilin, transcript variant X5
spliceosome-associated protein CWC27 homolog isoform X4
CWC27 spliceosome associated cyclophilin, transcript variant X6
spliceosome-associated protein CWC27 homolog isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
regulator of G protein signaling 7 binding protein
regulator of G-protein signaling 7-binding protein
ring finger protein 180, transcript variant X8
ring finger protein 180, transcript variant X5
ring finger protein 180, transcript variant X6
ring finger protein 180, transcript variant X1
ring finger protein 180, transcript variant X2
ring finger protein 180, transcript variant X4
ring finger protein 180, transcript variant X7
ring finger protein 180, transcript variant X10
ring finger protein 180, transcript variant X11
E3 ubiquitin-protein ligase RNF180 isoform X2
E3 ubiquitin-protein ligase RNF180 isoform X1
E3 ubiquitin-protein ligase RNF180 isoform X4
E3 ubiquitin-protein ligase RNF180 isoform X5
E3 ubiquitin-protein ligase RNF180 isoform X6
ring finger protein 180, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ring finger protein 180, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF180 isoform X3
ring finger protein 180, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF180 isoform X8
ring finger protein 180, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF180 isoform X9
ring finger protein 180, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF180 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123330542, transcript variant X1
uncharacterized LOC123330542, transcript variant X3
uncharacterized LOC123330542, transcript variant X5
uncharacterized LOC123330542, transcript variant X4
uncharacterized LOC123330542, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
DIM1 rRNA methyltransferase and ribosome maturation factor, transcript variant X1
DIM1 rRNA methyltransferase and ribosome maturation factor, transcript variant X2
probable dimethyladenosine transferase isoform X1
probable dimethyladenosine transferase isoform X2
kinesin family member 2A, transcript variant X2
kinesin family member 2A, transcript variant X1
kinesin family member 2A, transcript variant X4
kinesin family member 2A, transcript variant X3
uncharacterized LOC112580614, transcript variant X3
uncharacterized LOC112580614, transcript variant X1
uncharacterized LOC112580614, transcript variant X4
uncharacterized LOC112580614, transcript variant X2
zinc finger SWIM domain-containing protein 6
NADH:ubiquinone oxidoreductase complex assembly factor 2, transcript variant X1
NADH:ubiquinone oxidoreductase complex assembly factor 2, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 isoform X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 isoform X1
NADH:ubiquinone oxidoreductase complex assembly factor 2, transcript variant X3
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
ERCC excision repair 8, CSA ubiquitin ligase complex subunit, transcript variant X4
DNA excision repair protein ERCC-8 isoform X4
ERCC excision repair 8, CSA ubiquitin ligase complex subunit, transcript variant X1
ERCC excision repair 8, CSA ubiquitin ligase complex subunit, transcript variant X3
ERCC excision repair 8, CSA ubiquitin ligase complex subunit, transcript variant X2
ERCC excision repair 8, CSA ubiquitin ligase complex subunit, transcript variant X5
DNA excision repair protein ERCC-8 isoform X1
DNA excision repair protein ERCC-8 isoform X3
DNA excision repair protein ERCC-8 isoform X2
DNA excision repair protein ERCC-8 isoform X5
ELOVL fatty acid elongase 7, transcript variant X2
ELOVL fatty acid elongase 7, transcript variant X1
ELOVL fatty acid elongase 7, transcript variant X5
ELOVL fatty acid elongase 7, transcript variant X4
elongation of very long chain fatty acids protein 7 isoform X1
ELOVL fatty acid elongase 7, transcript variant X3
elongation of very long chain fatty acids protein 7 isoform X3
elongation of very long chain fatty acids protein 7 isoform X2
phosphodiesterase 4D, transcript variant X4
phosphodiesterase 4D, transcript variant X5
phosphodiesterase 4D, transcript variant X3
uncharacterized LOC102399935, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
uncharacterized LOC102399935, transcript variant X1
phosphodiesterase 4D, transcript variant X6
phosphodiesterase 4D, transcript variant X10
phosphodiesterase 4D, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 251 Proteins
phosphodiesterase 4D, transcript variant X8
phosphodiesterase 4D, transcript variant X9
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X3
phosphodiesterase 4D, transcript variant X1
phosphodiesterase 4D, transcript variant X12
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X5
phosphodiesterase 4D, transcript variant X11
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X4
phosphodiesterase 4D, transcript variant X16
phosphodiesterase 4D, transcript variant X17
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X9
phosphodiesterase 4D, transcript variant X14
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X7
phosphodiesterase 4D, transcript variant X13
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X6
phosphodiesterase 4D, transcript variant X2
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
phosphodiesterase 4D, transcript variant X15
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X8
phosphodiesterase 4D, transcript variant X18
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X10
RAB3C, member RAS oncogene family, transcript variant X5
RAB3C, member RAS oncogene family, transcript variant X2
RAB3C, member RAS oncogene family, transcript variant X1
RAB3C, member RAS oncogene family, transcript variant X4
RAB3C, member RAS oncogene family, transcript variant X3
RAB3C, member RAS oncogene family, transcript variant X6
probable inactive 1-aminocyclopropane-1-carboxylate synthase-like protein 2
GRB2 binding adaptor protein, transmembrane
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 394 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
GC-rich promoter binding protein 1, transcript variant X4
GC-rich promoter binding protein 1, transcript variant X5
GC-rich promoter binding protein 1, transcript variant X3
GC-rich promoter binding protein 1, transcript variant X2
GC-rich promoter binding protein 1, transcript variant X1
GC-rich promoter binding protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
mesoderm induction early response protein 3
SET domain containing 9, transcript variant X3
SET domain-containing protein 9 isoform X3
SET domain containing 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
SET domain containing 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SET domain-containing protein 9 isoform X1
SET domain-containing protein 9 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
mitogen-activated protein kinase kinase kinase 1, transcript variant X2
mitogen-activated protein kinase kinase kinase 1, transcript variant X1
mitogen-activated protein kinase kinase kinase 1, transcript variant X4
mitogen-activated protein kinase kinase kinase 1, transcript variant X3
mitogen-activated protein kinase kinase kinase 1 isoform X2
mitogen-activated protein kinase kinase kinase 1 isoform X1
mitogen-activated protein kinase kinase kinase 1 isoform X3
mitogen-activated protein kinase kinase kinase 1 isoform X4
uncharacterized LOC123330630, transcript variant X1
uncharacterized LOC123330630, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain 55, transcript variant X4
ankyrin repeat domain 55, transcript variant X2
ankyrin repeat domain 55, transcript variant X1
ankyrin repeat domain 55, transcript variant X5
ankyrin repeat domain 55, transcript variant X3
ankyrin repeat domain-containing protein 55 isoform X1
ankyrin repeat domain-containing protein 55 isoform X3
ankyrin repeat domain-containing protein 55 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain-containing protein 55 isoform X2
interleukin 6 cytokine family signal transducer
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
interleukin 31 receptor A, transcript variant X1
interleukin 31 receptor A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
interleukin 31 receptor A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
VASA; VASA1; VASA2; VASA3; VASA4; VASA5; VASA6
DEAD-box helicase 4; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
DEAD-box helicase 4, transcript variant X4
DEAD-box helicase 4, transcript variant X3
DEAD-box helicase 4, transcript variant X2
DEAD-box helicase 4, transcript variant X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001319794.1
annotated by transcript or proteomic data
The RefSeq transcript has 6 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
probable ATP-dependent RNA helicase DDX4 isoform X4
probable ATP-dependent RNA helicase DDX4 isoform X3
probable ATP-dependent RNA helicase DDX4 isoform X2
probable ATP-dependent RNA helicase DDX4 isoform X1
similar to AA sequence (same species):RefSeq:NP_001306723.1
The RefSeq protein has 1 substitution compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
probable ATP-dependent RNA helicase DDX4
solute carrier family 38 member 9, transcript variant X3
solute carrier family 38 member 9, transcript variant X6
solute carrier family 38 member 9, transcript variant X2
solute carrier family 38 member 9, transcript variant X5
solute carrier family 38 member 9, transcript variant X1
solute carrier family 38 member 9, transcript variant X7
solute carrier family 38 member 9, transcript variant X4
sodium-coupled neutral amino acid transporter 9 isoform X1
sodium-coupled neutral amino acid transporter 9 isoform X4
sodium-coupled neutral amino acid transporter 9 isoform X3
sodium-coupled neutral amino acid transporter 9 isoform X2
phospholipid phosphatase 1, transcript variant X1
phospholipid phosphatase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62% coverage of the annotated genomic feature by RNAseq alignments
multiciliate differentiation and DNA synthesis associated cell cycle protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cell division cycle protein 20 homolog B
glutathione peroxidase 8 (putative), transcript variant X2
glutathione peroxidase 8 (putative), transcript variant X1
probable glutathione peroxidase 8 isoform X1
probable glutathione peroxidase 8 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00598
chondroitin sulfate proteoglycan 4, transcript variant X2
chondroitin sulfate proteoglycan 4 isoform X2
chondroitin sulfate proteoglycan 4, transcript variant X1
chondroitin sulfate proteoglycan 4, transcript variant X3
chondroitin sulfate proteoglycan 4 isoform X1
chondroitin sulfate proteoglycan 4 isoform X3
heat shock protein family B (small) member 3
ADP ribosylation factor like GTPase 15, transcript variant X8
ADP-ribosylation factor-like protein 15 isoform X8
ADP ribosylation factor like GTPase 15, transcript variant X5
ADP ribosylation factor like GTPase 15, transcript variant X2
ADP ribosylation factor like GTPase 15, transcript variant X3
ADP ribosylation factor like GTPase 15, transcript variant X7
ADP ribosylation factor like GTPase 15, transcript variant X6
ADP ribosylation factor like GTPase 15, transcript variant X9
ADP ribosylation factor like GTPase 15, transcript variant X1
ADP ribosylation factor like GTPase 15, transcript variant X4
ADP-ribosylation factor-like protein 15 isoform X1
ADP-ribosylation factor-like protein 15 isoform X5
ADP-ribosylation factor-like protein 15 isoform X4
ADP-ribosylation factor-like protein 15 isoform X9
ADP-ribosylation factor-like protein 15 isoform X2
ADP-ribosylation factor-like protein 15 isoform X7
ADP-ribosylation factor-like protein 15 isoform X6
ADP-ribosylation factor-like protein 15 isoform X3
NADH:ubiquinone oxidoreductase subunit S4
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial
follistatin; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001290906.1
The RefSeq transcript has 3 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001277835.1
COORDINATES: ab initio prediction:SignalP:4.0
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (A5YT95.1); glycosylation site
propagated from UniProtKB/Swiss-Prot (A5YT95.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
molybdenum cofactor synthesis 2, transcript variant X3
molybdenum cofactor synthesis 2, transcript variant X5
molybdenum cofactor synthesis 2, transcript variant X4
molybdenum cofactor synthesis 2, transcript variant X2
molybdenum cofactor synthesis 2, transcript variant X1
molybdopterin synthase catalytic subunit
integrin subunit alpha 2, transcript variant X2
integrin subunit alpha 2, transcript variant X1
pelota mRNA surveillance and ribosome rescue factor
uncharacterized LOC112580626, transcript variant X1
uncharacterized LOC112580626, transcript variant X2
uncharacterized LOC112580626, transcript variant X3
ISL LIM homeobox 1, transcript variant X1
insulin gene enhancer protein ISL-1 isoform X1
ISL LIM homeobox 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
insulin gene enhancer protein ISL-1 isoform X2
poly(ADP-ribose) polymerase family member 8, transcript variant X2
poly(ADP-ribose) polymerase family member 8, transcript variant X3
poly(ADP-ribose) polymerase family member 8, transcript variant X1
protein mono-ADP-ribosyltransferase PARP8 isoform X2
protein mono-ADP-ribosyltransferase PARP8 isoform X1
protein mono-ADP-ribosyltransferase PARP8 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
hyperpolarization activated cyclic nucleotide gated potassium channel 1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
39S ribosomal protein S30, mitochondrial
fibroblast growth factor 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
fibroblast growth factor 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
nicotinamide nucleotide transhydrogenase, transcript variant X2
nicotinamide nucleotide transhydrogenase, transcript variant X4
nicotinamide nucleotide transhydrogenase, transcript variant X3
nicotinamide nucleotide transhydrogenase, transcript variant X1
nicotinamide nucleotide transhydrogenase, transcript variant X5
NAD(P) transhydrogenase, mitochondrial isoform X1
NAD(P) transhydrogenase, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
poly(A) binding protein interacting protein 1, transcript variant X3
poly(A) binding protein interacting protein 1, transcript variant X1
poly(A) binding protein interacting protein 1, transcript variant X2
polyadenylate-binding protein-interacting protein 1 isoform X1
polyadenylate-binding protein-interacting protein 1 isoform X2
polyadenylate-binding protein-interacting protein 1 isoform X3
chromosome 19 C5orf34 homolog, transcript variant X5
chromosome 19 C5orf34 homolog, transcript variant X2
chromosome 19 C5orf34 homolog, transcript variant X4
chromosome 19 C5orf34 homolog, transcript variant X3
chromosome 19 C5orf34 homolog, transcript variant X1
uncharacterized protein C5orf34 homolog isoform X1
uncharacterized protein C5orf34 homolog isoform X2
transmembrane protein 267, transcript variant X4
transmembrane protein 267, transcript variant X2
transmembrane protein 267, transcript variant X3
transmembrane protein 267, transcript variant X1
transmembrane protein 267, transcript variant X5
C-C motif chemokine ligand 28, transcript variant X2
C-C motif chemokine ligand 28, transcript variant X1
3-hydroxy-3-methylglutaryl-CoA synthase 1, transcript variant X5
3-hydroxy-3-methylglutaryl-CoA synthase 1, transcript variant X4
3-hydroxy-3-methylglutaryl-CoA synthase 1, transcript variant X2
3-hydroxy-3-methylglutaryl-CoA synthase 1, transcript variant X3
3-hydroxy-3-methylglutaryl-CoA synthase 1, transcript variant X1
hydroxymethylglutaryl-CoA synthase, cytoplasmic
zinc finger protein 131, transcript variant X4
zinc finger protein 131, transcript variant X1
zinc finger protein 131, transcript variant X6
zinc finger protein 131, transcript variant X3
zinc finger protein 131, transcript variant X5
zinc finger protein 131, transcript variant X2
zinc finger protein 131, transcript variant X7
zinc finger protein 131, transcript variant X8
zinc finger protein 131, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain containing 152, transcript variant X3
coiled-coil domain containing 152, transcript variant X1
coiled-coil domain containing 152, transcript variant X2
coiled-coil domain-containing protein 152 isoform X3
coiled-coil domain-containing protein 152 isoform X1
coiled-coil domain-containing protein 152 isoform X2
uncharacterized LOC112580628, transcript variant X1
uncharacterized LOC112580628, transcript variant X3
uncharacterized LOC112580628, transcript variant X4
uncharacterized LOC112580628, transcript variant X2
growth hormone receptor; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
growth hormone receptor, transcript variant X9
growth hormone receptor, transcript variant X1
growth hormone receptor, transcript variant X3
growth hormone receptor, transcript variant X8
growth hormone receptor, transcript variant X2
growth hormone receptor, transcript variant X6
growth hormone receptor, transcript variant X7
growth hormone receptor, transcript variant X10
growth hormone receptor, transcript variant X4
growth hormone receptor, transcript variant X5
similar to RNA sequence, mRNA (same species):RefSeq:NM_001290971.1
The RefSeq transcript has 6 substitutions, 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001277900.1
uncharacterized LOC123330637, transcript variant X1
uncharacterized LOC123330637, transcript variant X3
uncharacterized LOC123330637, transcript variant X2
uncharacterized LOC123330556, transcript variant X2
uncharacterized LOC123330556, transcript variant X1
uncharacterized LOC123330556, transcript variant X3
uncharacterized LOC123330553, transcript variant X3
uncharacterized LOC123330553, transcript variant X1
uncharacterized LOC123330553, transcript variant X2
uncharacterized LOC123330553, transcript variant X4
RAB7A interacting MON1-CCZ1 complex subunit 1, transcript variant X2
RAB7A interacting MON1-CCZ1 complex subunit 1, transcript variant X1
UPF0600 protein C5orf51 homolog isoform X2
UPF0600 protein C5orf51 homolog isoform X1
3-oxoacid CoA-transferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
3-oxoacid CoA-transferase 1, transcript variant X1
succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial isoform X1
succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial isoform X2
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
phosphatidylinositol specific phospholipase C X domain containing 3
maestro heat like repeat family member 2B
maestro heat-like repeat-containing protein family member 2B
caspase recruitment domain family member 6, transcript variant X1
caspase recruitment domain family member 6, transcript variant X2
caspase recruitment domain-containing protein 6 isoform X1
caspase recruitment domain-containing protein 6 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00577
protein kinase AMP-activated catalytic subunit alpha 1, transcript variant X1
protein kinase AMP-activated catalytic subunit alpha 1, transcript variant X4
protein kinase AMP-activated catalytic subunit alpha 1, transcript variant X3
protein kinase AMP-activated catalytic subunit alpha 1, transcript variant X2
protein kinase AMP-activated catalytic subunit alpha 1, transcript variant X5
5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X1
5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X2
5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X3
tetratricopeptide repeat domain 33, transcript variant X2
tetratricopeptide repeat domain 33, transcript variant X3
tetratricopeptide repeat domain 33, transcript variant X1
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
DAB adaptor protein 2, transcript variant X2
DAB adaptor protein 2, transcript variant X1
DAB adaptor protein 2, transcript variant X3
similar to RNA sequence (same species):INSD:GDJS01043708.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 393 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 393 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC102396391, transcript variant X2
uncharacterized LOC102396391, transcript variant X1
FYN binding protein 1, transcript variant X1
FYN binding protein 1, transcript variant X2
uncharacterized LOC102396391, transcript variant X3
uncharacterized LOC102396391, transcript variant X4
FYN binding protein 1, transcript variant X3
RPTOR independent companion of MTOR complex 2, transcript variant X1
RPTOR independent companion of MTOR complex 2, transcript variant X2
rapamycin-insensitive companion of mTOR isoform X1
rapamycin-insensitive companion of mTOR isoform X2
RPTOR independent companion of MTOR complex 2, transcript variant X3
rapamycin-insensitive companion of mTOR isoform X3
oncostatin M receptor, transcript variant X14
oncostatin-M-specific receptor subunit beta isoform X8
oncostatin M receptor, transcript variant X6
oncostatin M receptor, transcript variant X10
oncostatin M receptor, transcript variant X11
oncostatin M receptor, transcript variant X1
oncostatin M receptor, transcript variant X12
oncostatin M receptor, transcript variant X4
oncostatin M receptor, transcript variant X8
oncostatin M receptor, transcript variant X9
oncostatin M receptor, transcript variant X2
oncostatin M receptor, transcript variant X5
oncostatin M receptor, transcript variant X7
oncostatin M receptor, transcript variant X3
oncostatin M receptor, transcript variant X13
oncostatin-M-specific receptor subunit beta isoform X4
oncostatin-M-specific receptor subunit beta isoform X2
oncostatin-M-specific receptor subunit beta isoform X6
oncostatin-M-specific receptor subunit beta isoform X3
oncostatin-M-specific receptor subunit beta isoform X5
oncostatin-M-specific receptor subunit beta isoform X1
oncostatin-M-specific receptor subunit beta isoform X7
uncharacterized LOC102395220, transcript variant X4
uncharacterized LOC102395220, transcript variant X5
uncharacterized LOC102395220, transcript variant X2
uncharacterized LOC102395220, transcript variant X3
uncharacterized LOC102395220, transcript variant X1
LIF receptor subunit alpha, transcript variant X2
leukemia inhibitory factor receptor isoform X2
LIF receptor subunit alpha, transcript variant X4
LIF receptor subunit alpha, transcript variant X8
LIF receptor subunit alpha, transcript variant X1
leukemia inhibitory factor receptor isoform X1
LIF receptor subunit alpha, transcript variant X3
LIF receptor subunit alpha, transcript variant X7
LIF receptor subunit alpha, transcript variant X9
LIF receptor subunit alpha, transcript variant X5
LIF receptor subunit alpha, transcript variant X10
LIF receptor subunit alpha, transcript variant X6
leukemia inhibitory factor receptor isoform X3
leukemia inhibitory factor receptor isoform X4
EGF like, fibronectin type III and laminin G domains, transcript variant X1
EGF like, fibronectin type III and laminin G domains, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00416
glial cell derived neurotrophic factor; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
glial cell derived neurotrophic factor, transcript variant X1
glial cell derived neurotrophic factor, transcript variant X2
glial cell derived neurotrophic factor, transcript variant X3
glial cell derived neurotrophic factor, transcript variant X4
similar to RNA sequence, mRNA (same species):RefSeq:NM_001290896.1
The RefSeq transcript has 2 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
glial cell line-derived neurotrophic factor isoform X1
similar to AA sequence (same species):RefSeq:NP_001277825.1
glial cell line-derived neurotrophic factor precursor
glial cell line-derived neurotrophic factor isoform X2
glial cell derived neurotrophic factor, transcript variant X6
glial cell derived neurotrophic factor, transcript variant X5
glial cell line-derived neurotrophic factor isoform X3
glial cell line-derived neurotrophic factor isoform X4
ciliogenesis and planar polarity effector 1, transcript variant X8
ciliogenesis and planar polarity effector 1, transcript variant X7
ciliogenesis and planar polarity effector 1, transcript variant X1
ciliogenesis and planar polarity effector 1, transcript variant X6
ciliogenesis and planar polarity effector 1, transcript variant X4
ciliogenesis and planar polarity effector 1, transcript variant X5
ciliogenesis and planar polarity effector 1, transcript variant X3
ciliogenesis and planar polarity effector 1, transcript variant X2
ciliogenesis and planar polarity effector 1 isoform X1
ciliogenesis and planar polarity effector 1 isoform X5
ciliogenesis and planar polarity effector 1 isoform X3
ciliogenesis and planar polarity effector 1 isoform X4
ciliogenesis and planar polarity effector 1 isoform X2
ciliogenesis and planar polarity effector 1 isoform X6
ciliogenesis and planar polarity effector 1 isoform X7
NIPBL cohesin loading factor, transcript variant X5
NIPBL cohesin loading factor, transcript variant X2
NIPBL cohesin loading factor, transcript variant X3
NIPBL cohesin loading factor, transcript variant X1
NIPBL cohesin loading factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 112 samples with support for all annotated introns
solute carrier family 1 member 3, transcript variant X1
solute carrier family 1 member 3, transcript variant X2
excitatory amino acid transporter 1 isoform X1
excitatory amino acid transporter 1 isoform X2
RAN binding protein 3 like, transcript variant X2
RAN binding protein 3 like, transcript variant X1
NAD kinase 2, mitochondrial, transcript variant X1
NAD kinase 2, mitochondrial, transcript variant X2
S-phase kinase associated protein 2, transcript variant X2
S-phase kinase associated protein 2, transcript variant X1
S-phase kinase associated protein 2, transcript variant X4
S-phase kinase associated protein 2, transcript variant X3
S-phase kinase-associated protein 2 isoform X2
S-phase kinase-associated protein 2 isoform X1
S-phase kinase-associated protein 2 isoform X3
LMBR1 domain containing 2, transcript variant X5
LMBR1 domain containing 2, transcript variant X2
LMBR1 domain containing 2, transcript variant X3
LMBR1 domain containing 2, transcript variant X1
LMBR1 domain containing 2, transcript variant X6
LMBR1 domain containing 2, transcript variant X7
LMBR1 domain containing 2, transcript variant X9
LMBR1 domain containing 2, transcript variant X4
LMBR1 domain containing 2, transcript variant X8
G-protein coupled receptor-associated protein LMBRD2 isoform X3
G-protein coupled receptor-associated protein LMBRD2 isoform X1
G-protein coupled receptor-associated protein LMBRD2 isoform X2
G-protein coupled receptor-associated protein LMBRD2 isoform X5
G-protein coupled receptor-associated protein LMBRD2 isoform X4
UDP-glucuronosyltransferase 3A1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
UDP-glucuronosyltransferase 3A1 isoform X1
UDP-glucuronosyltransferase 3A1, transcript variant X2
UDP-glucuronosyltransferase 3A1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
calcyphosine like, transcript variant X7
calcyphosine like, transcript variant X3
calcyphosine like, transcript variant X4
calcyphosine like, transcript variant X1
calcyphosine like, transcript variant X2
calcyphosine like, transcript variant X5
calcyphosine like, transcript variant X6
interleukin 7 receptor, transcript variant X3
interleukin 7 receptor, transcript variant X1
interleukin 7 receptor, transcript variant X2
interleukin 7 receptor, transcript variant X4
interleukin-7 receptor subunit alpha isoform X1
interleukin-7 receptor subunit alpha isoform X2
interleukin-7 receptor subunit alpha isoform X3
sperm flagellar 2, transcript variant X10
sperm flagellar 2, transcript variant X8
sperm flagellar 2, transcript variant X9
sperm flagellar 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sperm flagellar 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sperm flagellar 2, transcript variant X6
sperm flagellar 2, transcript variant X7
sperm flagellar 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sperm flagellar 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sperm flagellar 2, transcript variant X3
sperm flagellar 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sperm flagellar 2, transcript variant X2
prolactin receptor, transcript variant X4
prolactin receptor, transcript variant X2
prolactin receptor, transcript variant X3
prolactin receptor, transcript variant X1
prolactin receptor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
alanine--glyoxylate aminotransferase 2, mitochondrial
transfer RNA tyrosine (anticodon AUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
DnaJ heat shock protein family (Hsp40) member C21, transcript variant X2
DnaJ heat shock protein family (Hsp40) member C21, transcript variant X1
dnaJ homolog subfamily C member 21 isoform X1
dnaJ homolog subfamily C member 21 isoform X2
biogenesis of ribosomes BRX1, transcript variant X2
biogenesis of ribosomes BRX1, transcript variant X1
ribosome biogenesis protein BRX1 homolog isoform X2
ribosome biogenesis protein BRX1 homolog isoform X1
RAD1 checkpoint DNA exonuclease, transcript variant X4
RAD1 checkpoint DNA exonuclease, transcript variant X5
RAD1 checkpoint DNA exonuclease, transcript variant X1
RAD1 checkpoint DNA exonuclease, transcript variant X6
RAD1 checkpoint DNA exonuclease, transcript variant X3
RAD1 checkpoint DNA exonuclease, transcript variant X2
cell cycle checkpoint protein RAD1 isoform X2
cell cycle checkpoint protein RAD1 isoform X1
cell cycle checkpoint protein RAD1 isoform X3
tetratricopeptide repeat domain 23 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tetratricopeptide repeat domain 23 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
tetratricopeptide repeat domain 23 like, transcript variant X3
tetratricopeptide repeat protein 23-like isoform X1
tetratricopeptide repeat protein 23-like isoform X2
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
retinoic acid induced 14, transcript variant X3
retinoic acid induced 14, transcript variant X5
retinoic acid induced 14, transcript variant X6
retinoic acid induced 14, transcript variant X4
retinoic acid induced 14, transcript variant X1
retinoic acid induced 14, transcript variant X2
C1q and TNF related 3, transcript variant X1
C1q and TNF related 3, transcript variant X2
C1q and TNF related 3, transcript variant X3
complement C1q tumor necrosis factor-related protein 3 isoform X1
complement C1q tumor necrosis factor-related protein 3 isoform X2
complement C1q tumor necrosis factor-related protein 3 isoform X3
alpha-methylacyl-CoA racemase, transcript variant X3
alpha-methylacyl-CoA racemase, transcript variant X1
alpha-methylacyl-CoA racemase, transcript variant X2
alpha-methylacyl-CoA racemase isoform X1
alpha-methylacyl-CoA racemase isoform X2
alpha-methylacyl-CoA racemase isoform X3
solute carrier family 45 member 2, transcript variant X2
solute carrier family 45 member 2, transcript variant X3
solute carrier family 45 member 2, transcript variant X1
membrane-associated transporter protein isoform X2
membrane-associated transporter protein isoform X1
membrane-associated transporter protein isoform X3
ADAM metallopeptidase with thrombospondin type 1 motif 12, transcript variant X1
A disintegrin and metalloproteinase with thrombospondin motifs 12 isoform X1
ADAM metallopeptidase with thrombospondin type 1 motif 12, transcript variant X3
ADAM metallopeptidase with thrombospondin type 1 motif 12, transcript variant X2
A disintegrin and metalloproteinase with thrombospondin motifs 12 isoform X2
uncharacterized LOC112580635, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC112580635, transcript variant X1
threonyl-tRNA synthetase 1, transcript variant X2
threonyl-tRNA synthetase 1, transcript variant X1
threonine--tRNA ligase 1, cytoplasmic isoform X1
threonine--tRNA ligase 1, cytoplasmic isoform X2
uncharacterized LOC112580636, transcript variant X1
uncharacterized LOC112580636, transcript variant X2
natriuretic peptide receptor 3, transcript variant X3
natriuretic peptide receptor 3, transcript variant X2
natriuretic peptide receptor 3, transcript variant X1
atrial natriuretic peptide receptor 3 isoform X3
atrial natriuretic peptide receptor 3 isoform X2
atrial natriuretic peptide receptor 3 isoform X1
activated RNA polymerase II transcriptional coactivator p15
zinc finger RNA binding protein, transcript variant X4
zinc finger RNA binding protein, transcript variant X1
zinc finger RNA binding protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 80 samples with support for all annotated introns
zinc finger RNA binding protein, transcript variant X2
zinc finger RNA binding protein, transcript variant X3
zinc finger RNA-binding protein isoform X1
zinc finger RNA-binding protein isoform X4
zinc finger RNA-binding protein isoform X2
zinc finger RNA-binding protein isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 5 bases in 5 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 5 bases in 5 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
similar to RNA sequence (same species):INSD:GDJS01048239.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 112 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 112 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
drosha ribonuclease III; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
drosha ribonuclease III, transcript variant X2
drosha ribonuclease III, transcript variant X1
drosha ribonuclease III, transcript variant X4
drosha ribonuclease III, transcript variant X3
similar to RNA sequence, mRNA (same species):RefSeq:NM_001319795.1
Derived by automated computational analysis using gene prediction method: BestRefSeq.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: keratin, type I cytoskeletal 39-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transfer RNA leucine (anticodon UAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA serine (anticodon GGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 43% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transcription initiation factor TFIID subunit 11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins
brain abundant membrane attached signal protein 1, transcript variant X2
brain abundant membrane attached signal protein 1, transcript variant X3
brain abundant membrane attached signal protein 1, transcript variant X1
reticulophagy regulator 1, transcript variant X1
reticulophagy regulator 1, transcript variant X4
reticulophagy regulator 1, transcript variant X3
reticulophagy regulator 1, transcript variant X2
membrane associated ring-CH-type finger 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 98 samples with support for all annotated introns
eukaryotic translation initiation factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
ANKH inorganic pyrophosphate transport regulator
uncharacterized LOC123330562, transcript variant X1
uncharacterized LOC123330562, transcript variant X2
OTU deubiquitinase with linear linkage specificity, transcript variant X4
OTU deubiquitinase with linear linkage specificity, transcript variant X5
OTU deubiquitinase with linear linkage specificity, transcript variant X3
OTU deubiquitinase with linear linkage specificity, transcript variant X1
OTU deubiquitinase with linear linkage specificity, transcript variant X2
ubiquitin thioesterase otulin isoform X4
ubiquitin thioesterase otulin isoform X1
ubiquitin thioesterase otulin isoform X5
ubiquitin thioesterase otulin isoform X3
ubiquitin thioesterase otulin isoform X2
uncharacterized LOC123330563, transcript variant X2
uncharacterized LOC123330563, transcript variant X1
OTU deubiquitinase with linear linkage specificity like, transcript variant X1
OTU deubiquitinase with linear linkage specificity like, transcript variant X2
OTU deubiquitinase with linear linkage specificity like, transcript variant X3
inactive ubiquitin thioesterase OTULINL isoform X1
inactive ubiquitin thioesterase OTULINL isoform X2
trio Rho guanine nucleotide exchange factor, transcript variant X2
trio Rho guanine nucleotide exchange factor, transcript variant X3
trio Rho guanine nucleotide exchange factor, transcript variant X1
trio Rho guanine nucleotide exchange factor, transcript variant X4
trio Rho guanine nucleotide exchange factor, transcript variant X5
triple functional domain protein isoform X2
triple functional domain protein isoform X3
triple functional domain protein isoform X1
triple functional domain protein isoform X4
triple functional domain protein isoform X5
trio Rho guanine nucleotide exchange factor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
trio Rho guanine nucleotide exchange factor, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
triple functional domain protein isoform X7
triple functional domain protein isoform X6
trio Rho guanine nucleotide exchange factor, transcript variant X8
triple functional domain protein isoform X8
trio Rho guanine nucleotide exchange factor, transcript variant X9
triple functional domain protein isoform X9
uncharacterized LOC123330643, transcript variant X2
uncharacterized LOC123330643, transcript variant X1
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
ankyrin repeat domain 33B, transcript variant X2
ankyrin repeat domain 33B, transcript variant X1
ankyrin repeat domain-containing protein 33B isoform X2
ankyrin repeat domain-containing protein 33B isoform X1
rhophilin associated tail protein 1 like, transcript variant X2
rhophilin associated tail protein 1 like, transcript variant X1
membrane associated ring-CH-type finger 6
uncharacterized LOC123330629, transcript variant X1
uncharacterized LOC123330629, transcript variant X2
carboxymethylenebutenolidase homolog, transcript variant X2
carboxymethylenebutenolidase homolog, transcript variant X1
ATP synthase c subunit lysine N-methyltransferase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
ATP synthase c subunit lysine N-methyltransferase, transcript variant X3
ATP synthase c subunit lysine N-methyltransferase, transcript variant X1
ATP synthase c subunit lysine N-methyltransferase, transcript variant X6
ATP synthase c subunit lysine N-methyltransferase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ATP synthase c subunit lysine N-methyltransferase, transcript variant X2
ATP synthase subunit C lysine N-methyltransferase isoform X3
ATP synthase subunit C lysine N-methyltransferase isoform X2
ATP synthase subunit C lysine N-methyltransferase isoform X5
ATP synthase subunit C lysine N-methyltransferase isoform X4
ATP synthase subunit C lysine N-methyltransferase isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF01156
transmembrane emp24 domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X5
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X4
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X3
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X1
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X6
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X2
methionine synthase reductase isoform X2
methionine synthase reductase isoform X1
methionine synthase reductase isoform X3
FAST kinase domains 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
FAST kinase domains 3, transcript variant X3
FAST kinase domains 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
FAST kinase domain-containing protein 3, mitochondrial isoform X1
FAST kinase domain-containing protein 3, mitochondrial isoform X2
uncharacterized LOC123330549, transcript variant X2
uncharacterized LOC123330549, transcript variant X1
terminal nucleotidyltransferase 4A, transcript variant X2
terminal nucleotidyltransferase 4A, transcript variant X1
terminal nucleotidyltransferase 4A isoform X2
terminal nucleotidyltransferase 4A isoform X1
steroid 5 alpha-reductase 1, transcript variant X1
steroid 5 alpha-reductase 1, transcript variant X3
steroid 5 alpha-reductase 1, transcript variant X2
3-oxo-5-alpha-steroid 4-dehydrogenase 1 isoform X1
steroid 5 alpha-reductase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
3-oxo-5-alpha-steroid 4-dehydrogenase 1 isoform X2
RNA cytosine C(5)-methyltransferase NSUN2
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
ubiquitin conjugating enzyme E2 Q family like 1
ubiquitin-conjugating enzyme E2Q-like protein 1
mediator of RNA polymerase II transcription subunit 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
transfer RNA glycine (anticodon ACC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
interactor of little elongation complex ELL subunit 1, transcript variant X3
interactor of little elongation complex ELL subunit 1, transcript variant X2
interactor of little elongation complex ELL subunit 1, transcript variant X1
little elongation complex subunit 1 isoform X2
little elongation complex subunit 1 isoform X1
little elongation complex subunit 1 isoform X3
interactor of little elongation complex ELL subunit 1, transcript variant X4
little elongation complex subunit 1 isoform X4
ADAM metallopeptidase with thrombospondin type 1 motif 16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ADAM metallopeptidase with thrombospondin type 1 motif 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 16 isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 16 isoform X1
ADAM metallopeptidase with thrombospondin type 1 motif 16, transcript variant X3
A disintegrin and metalloproteinase with thrombospondin motifs 16 isoform X3
iroquois-class homeodomain protein IRX-1
iroquois-class homeodomain protein IRX-2
uncharacterized LOC123330572, transcript variant X2
uncharacterized LOC123330572, transcript variant X1
uncharacterized LOC123330591, transcript variant X2
uncharacterized LOC123330591, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
iroquois homeobox 4, transcript variant X1
iroquois homeobox 4, transcript variant X2
iroquois homeobox 4, transcript variant X4
iroquois homeobox 4, transcript variant X3
iroquois-class homeodomain protein IRX-4 isoform X1
iroquois-class homeodomain protein IRX-4 isoform X2
iroquois-class homeodomain protein IRX-4 isoform X3
NADH:ubiquinone oxidoreductase subunit S6
NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial
mitochondrial ribosomal protein L36, transcript variant X1
mitochondrial ribosomal protein L36, transcript variant X2
39S ribosomal protein L36, mitochondrial
lysophosphatidylcholine acyltransferase 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sodium-dependent dopamine transporter
cleft lip and palate transmembrane protein 1-like protein isoform X1
cleft lip and palate transmembrane protein 1-like protein isoform X3
cleft lip and palate transmembrane protein 1-like protein isoform X2
cleft lip and palate transmembrane protein 1-like protein isoform X4
cleft lip and palate transmembrane protein 1-like protein isoform X5
telomerase reverse transcriptase, transcript variant X6
telomerase reverse transcriptase, transcript variant X7
telomerase reverse transcriptase, transcript variant X5
telomerase reverse transcriptase, transcript variant X1
telomerase reverse transcriptase, transcript variant X2
telomerase reverse transcriptase, transcript variant X3
telomerase reverse transcriptase, transcript variant X4
telomerase reverse transcriptase isoform X1
telomerase reverse transcriptase isoform X2
telomerase reverse transcriptase isoform X3
telomerase reverse transcriptase isoform X4
telomerase reverse transcriptase isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inactive sodium-dependent neutral amino acid transporter B(0)AT3
sodium-dependent neutral amino acid transporter B(0)AT1
solute carrier family 12 member 7, transcript variant X1
solute carrier family 12 member 7, transcript variant X2
solute carrier family 12 member 7, transcript variant X3
solute carrier family 12 member 7 isoform X1
solute carrier family 12 member 7 isoform X2
solute carrier family 12 member 7 isoform X3
solute carrier family 12 member 7, transcript variant X4
solute carrier family 12 member 7, transcript variant X5
solute carrier family 12 member 7 isoform X4
solute carrier family 12 member 7 isoform X5
NKD inhibitor of WNT signaling pathway 2
bromodomain containing 9, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
bromodomain containing 9, transcript variant X1
bromodomain containing 9, transcript variant X2
bromodomain containing 9, transcript variant X4
bromodomain containing 9, transcript variant X5
bromodomain containing 9, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 82 samples with support for all annotated introns
bromodomain containing 9, transcript variant X3
bromodomain containing 9, transcript variant X6
bromodomain containing 9, transcript variant X7
bromodomain-containing protein 9 isoform X1
bromodomain-containing protein 9 isoform X3
bromodomain-containing protein 9 isoform X2
bromodomain-containing protein 9 isoform X4
bromodomain-containing protein 9 isoform X6
bromodomain-containing protein 9 isoform X5
bromodomain-containing protein 9 isoform X7
bromodomain-containing protein 9 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
tubulin polymerization promoting protein, transcript variant X1
tubulin polymerization promoting protein, transcript variant X2
tubulin polymerization-promoting protein
centrosomal protein 72, transcript variant X2
centrosomal protein 72, transcript variant X8
centrosomal protein 72, transcript variant X1
centrosomal protein 72, transcript variant X3
centrosomal protein 72, transcript variant X4
centrosomal protein 72, transcript variant X5
centrosomal protein 72, transcript variant X9
centrosomal protein of 72 kDa isoform X2
centrosomal protein of 72 kDa isoform X8
centrosomal protein of 72 kDa isoform X1
centrosomal protein of 72 kDa isoform X4
centrosomal protein of 72 kDa isoform X5
centrosomal protein of 72 kDa isoform X9
centrosomal protein of 72 kDa isoform X3
centrosomal protein 72, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
centrosomal protein 72, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
centrosomal protein of 72 kDa isoform X7
centrosomal protein of 72 kDa isoform X6
programmed cell death 6, transcript variant X3
programmed cell death 6, transcript variant X2
programmed cell death 6, transcript variant X1
programmed cell death protein 6 isoform X3
programmed cell death protein 6 isoform X2
programmed cell death protein 6 isoform X1
succinate dehydrogenase complex flavoprotein subunit A
succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial
coiled-coil domain-containing protein 127
leucine-rich repeat-containing protein 14B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments